Seeger Weiss Products Liability Actions Against Pfizer Involving Rezulin
Seeger Weiss serves as a court-appointed member of the Plaintiffs' Executive Committee in federal Rezulin litigation and as a member of the Steering Committee in the New Jersey Rezulin litigation. Seeger Weiss has played a major role in products liability actions against Pfizer and Warner Lambert involving Rezulin, a prescription drug used to treat Type II diabetes. The firm is a court-appointed member of the Executive Committee in the federal suits coordinated by the Judicial Panel on Multidistrict Litigation ("JPML") before Judge Lewis A. Kaplan in the U.S. District Court for the Southern District of New York. The firm is also a member of the New Jersey Rezulin Steering Committee in In re: Rezulin Litigation, currently pending before the Superior Court of New Jersey, Middlesex County. The firm is counsel to numerous individuals who have commenced personal injury damage actions in various courts throughout the country.
Seeger Weiss Recovers $2 Million Verdict Against Pfizer For Liver Injury Resulting From Rezulin Use
In March 2003, following a six-week jury trial led by founding partner Chris Seeger, the firm achieved a $2 million verdict against Pfizer on behalf of Concepcion Morgado, a Brooklyn resident who sustained liver injury and was hospitalized for 10 days following her Rezulin use. The case was the first Rezulin matter to be tried in New York and represented a watershed result in the nationwide Rezulin litigation. Seeger Weiss subsequently reached a 'global' settlement with Pfizer, in which it recovered several million dollars on behalf of all of its Rezulin user clients.
